The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the ...

The main harm comes from false-positive ultrasounds, which often must be confirmed by an angiogram. About 1% of people get a ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) 74th Annual Scientific Session and Expo in Chicago, March 29-31.

It does not necessarily reflect the view of The Herald. A poster in York appearing to depict Donald Trump and other politicians wearing Nazi uniforms was inspired by “rage at the current state of the ...

Abstract: Objective: Computational modelling of ascending thoracic aortic aneurysms (ATAA) typically assumes zerodisplacement at the model's inlet. In this study we incorporated different types of ...

Bioprosthetic valve dysfunction and reoperations/reinterventions are common after aortic valve replacement (AVR) with bioprosthetic valves, leading to cycles of left ...

Background: Following transcatheter aortic valve replacement, acute coronary obstruction is infrequent but potentially life-threatening, while delayed coronary obstruction is even more uncommon. Case ...

self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling stroke at five years compared with those whose valves were replaced through standard ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years, strong valve ...